NFG
GNMK

Next Financial Group’s GenMark Diagnostics, Inc GNMK Stock Holding History

Next Financial Group’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-413
Closed -$3K – 2477
2019
Q2 		$3K Buy
+413
New +$2.91K ﹤0.01% 2068
2019
Q1 		– Sell
-2,239
Closed -$11K – 2232
2018
Q4 		$11K Buy
2,239
+1,825
+441% +$9.5K ﹤0.01% 1329
2018
Q3 		$3K Buy
+414
New +$3.04K ﹤0.01% 1283
2017
Q4 		– Sell
-210
Closed -$2K – 1578
2017
Q3 		$2K Sell
210
-479
-70% -$4.98K ﹤0.01% 1645
2017
Q2 		$8K Buy
689
+199
+41% +$2.54K ﹤0.01% 1425
2017
Q1 		$6K Sell
490
-350
-42% -$4.21K ﹤0.01% 1484
2016
Q4 		$10K Hold
840
– – ﹤0.01% 1668
2016
Q3 		$10K Buy
+840
New +$8.11K ﹤0.01% 1665

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Next Financial Group's GNMK Position: Q3 2019 in Review

Next Financial Group sold out of GenMark Diagnostics, Inc (GNMK) in Q3 2019, closing a stake of 413 shares — an estimated $3K sold.

Next Financial Group first reported a position in GNMK in Q3 2016 and held it in 8 quarters. The position peaked at $11K in Q4 2018. 110 funds tracked by Wall St. Rank hold GNMK as of Q3 2019.

  • Next Financial Group reported no remaining GenMark Diagnostics, Inc position as of Q3 2019 after selling out during the quarter.
  • Next Financial Group sold 413 GenMark Diagnostics, Inc shares in Q3 2019, an estimated $3K.
  • Next Financial Group first reported a position in GenMark Diagnostics, Inc in Q3 2016 and held it in 8 quarters.
  • Next Financial Group's GenMark Diagnostics, Inc position peaked at $11K in Q4 2018.
  • 110 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q3 2019.

Based on Next Financial Group's 13F filing for Q3 2019, filed 17 Oct 2019.